Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Early Stage Parkinson's Disease”

112 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 112 results

Testing effectiveness (Phase 2)Study completedNCT00442780
What this trial is testing

Dose-Finding Safety Study of BIIB014 in Early-Stage Parkinson's Disease

Who this might be right for
Parkinson's Disease
Biogen 36
Not applicableStudy completedNCT03645226
What this trial is testing

Gut Microbiota Across Early Stages of Synucleinopathy: From High-risk Relatives, REM Sleep Behavior Disorder to Early Parkinson's Disease

Who this might be right for
REM Sleep Behavior Disorder
Chinese University of Hong Kong 441
Not applicableStudy completedNCT00282152
What this trial is testing

Deep Brain Stimulation (DBS) for Early Stage Parkinson's Disease (PD)

Who this might be right for
Parkinson's Disease
Vanderbilt University Medical Center 37
Large-scale testing (Phase 3)Study completedNCT04978597
What this trial is testing

Early ParkinSon wIth L-DOPA/DDCI and OpicapoNe (EPSILON Study)

Who this might be right for
Parkinson
Bial - Portela C S.A. 410
Large-scale testing (Phase 3)Study completedNCT04455555
What this trial is testing

Efficacy and Safety of Rotigotine in the Treatment of Patients With Early Stage of Primary Parkinson's Disease

Who this might be right for
Parkinson's Disease
Peking University Third Hospital 294
Testing effectiveness (Phase 2)Looking for participantsNCT06680830
What this trial is testing

Study and Open-Label Extension of NEU-411 in Companion Diagnostic-Positive Participants With Early Parkinson's Disease

Who this might be right for
Parkinson DiseaseParkinsonIdiopathic Parkinson Disease+2 more
Neuron23 Inc. 150
Not applicableStudy completedNCT04340492
What this trial is testing

Education for Adapted Physical Activity in Parkinson's Disease

Who this might be right for
Parkinson Disease
University Hospital, Lille 89
Testing effectiveness (Phase 2)Study completedNCT04995081
What this trial is testing

Clinical Trial for Parkinson's Disease Using Allogeneic HB-adMSCs (Early and Moderate PD)

Who this might be right for
Parkinson Disease
Hope Biosciences Research Foundation 60
Not applicableLooking for participantsNCT05286736
What this trial is testing

Neuroplasticity in Parkinson's Disease

Who this might be right for
ParkinsonParkinson Disease
University of Minnesota 50
Large-scale testing (Phase 3)Study completedNCT00335166
What this trial is testing

SLV 308 and Pramipexole for Treatment of Patients With Early Parkinson Disease

Who this might be right for
Early Stage Parkinson Disease
Solvay Pharmaceuticals 330
Testing effectiveness (Phase 2)Study completedNCT04658186
What this trial is testing

A 18-month Study to Evaluate the Efficacy, Safety, Tolerability and Pharmacokinetics of Oral UCB0599 in Study Participants With Early-stage Parkinson's Disease

Who this might be right for
Early-stage Parkinson's Disease
UCB Biopharma SRL 496
Testing effectiveness (Phase 2)Study completedNCT00407212
What this trial is testing

Three Doses of TCH346 in Patients With Early Parkinson's Disease to Evaluate Safety and Efficacy

Who this might be right for
Parkinson's Disease
Novartis 301
Early research (Phase 1)Study completedNCT02459886
What this trial is testing

Single-Ascending Dose Study of BIIB054 in Healthy Participants and Early Parkinson's Disease

Who this might be right for
Parkinson's DiseaseHealthy
Biogen 66
Early research (Phase 1)Study completedNCT02055274
What this trial is testing

Pharmacokinetics and Safety Study of LY03003 in Patients With Early-stage Parkinson's Disease

Who this might be right for
Parkinson's Disease
Luye Pharma Group Ltd. 39
Testing effectiveness (Phase 2)Study completedNCT00623324
What this trial is testing

The Effects of Aplindore on the Treatment of Signs and Symptoms of Parkinson's Disease

Who this might be right for
Early Stage Parkinson's Disease
Ligand Pharmaceuticals 40
Large-scale testing (Phase 3)Study completedNCT02168842
What this trial is testing

Efficacy of Isradipine in Early Parkinson Disease

Who this might be right for
Parkinson Disease
University of Rochester 336
Large-scale testing (Phase 3)Study completedNCT00243945
What this trial is testing

A Trial to Evaluate the Effects of Rotigotine Transdermal Patch on Early Morning Motor Impairment and Sleep Disorders Idiopathic Parkinson's Disease

Who this might be right for
IDIOPATHIC PARKINSON'S DISEASE
UCB Pharma 58
Testing effectiveness (Phase 2)Ended earlyNCT01227681
What this trial is testing

Study of the Neuro-protective Effect of Granulocyte-colony Stimulating Factor on Early Stage Parkinson's Disease

Who this might be right for
Parkinson Disease
Buddhist Tzu Chi General Hospital 4
Not applicableStudy completedNCT04692116
What this trial is testing

Parkinson's Disease (PD) Treated With Focused Ultrasound Subthalamotomy at an Early Stage

Who this might be right for
Parkinson Disease
Fundación de investigación HM 12
Not applicableLooking for participantsNCT06248073
What this trial is testing

Effectiveness of Online Program and Task-related Training for Parkinson's Disease

Who this might be right for
Parkinson DiseaseOccupational TherapyTelerehabilitation+1 more
Chang Gung University 100
Load More Results